Work

Impact of prior chemotherapy (CT) on dabrafenib plus trametinib (D + T) outcomes in BRAF V600E –mutated metastatic non–small cell lung cancer (NSCLC): A post hoc analysis.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e20666

Authors: Jianya Zhou, Yan Lei, Manar Aoun, Su Miin Ong, Yixiang Mao, Qian Xu

Institutions: First Affiliated Hospital Zhejiang University, Novartis (China), Novartis (Switzerland)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162685933

Cites:

Cited by:

Related to: